Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Aifeimu Technology is a specialized chemical manufacturer and CDMO based in Ganzhou, China, focusing on pharmaceutical intermediates and fine chemicals. The company provides research, development, and production services for high-end chemical building blocks, with a particular emphasis on fluorine-containing compounds and complex heterocyclic structures. Their product portfolio supports the synthesis of various active pharmaceutical ingredients (APIs) in therapeutic areas such as oncology and antiviral research, including intermediates for drugs like Enzalutamide and Apalutamide. Aifeimu operates advanced manufacturing facilities designed for custom synthesis and large-scale production to meet global pharmaceutical standards. The company serves as a key partner in the drug development supply chain for international biotech and pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Aifeimu Technology.